Transcode Therapeutics, Inc. · NASDAQ:RNAZ

Goldman Sachs Group Inc reported a 5.90% stake in Transcode Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Aug 14, 2025

Goldman Sachs Group Inc reported a 5.90% stake in Transcode Therapeutics, Inc., 49,018 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).

Stake
5.90%
Shares
49,018
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.5.90%49,018
GOLDMAN SACHS & CO. LLC5.90%49,018

Source

View original at SEC

Related